MANAGEMENT OF PSORIASIS THROUGH SHODHANA

AN OPEN LABEL SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFECT OF VAMANA AND VIRECHANA IN THE MANAGEMENT OF PSORIASIS AND ITS IMPACT ON IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037667

Enrollment

Registered

2021-10-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: PASI Score: > 10 Chronicity: 5-10 years Patients having the clinical features of Psoriasis (Kitibha Kushtha).

Exclusion criteria

Exclusion criteria: PASI score Chronicity of more than 10 years Patients with Severe Systemic disorders. Pregnant women and lactating mothers Patients unfit for Rookshana Snehana, Swedana,Vamana and Virechana Karma.

Design outcomes

Primary

Measure	Time frame
1.Symptomatic Relief in signs and symptoms of Psoriasis 2.Reduction in Psoriasis Area and Severity Index (PASI) Score. 3.Changes in Immunological and inflammatory Biomarkers 4.Changes in Biochemical Parameters. Timepoint: 0th day,7th day ,14th day,23rd day,40th day,80th day	—

Secondary

Measure	Time frame
Improvement in quality of lifeTimepoint: 0th day,7th day ,14th day,23rd day,40th day,80th day	—

Countries

India

Contacts

Public ContactDr Latika

All India Institute of Ayurveda

drprasanthd@gmail.com9895174060

Outcome results